| 1 |
30787885 | D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression? | 2019 |
1 |
| 2 |
29274788 | Human d-amino acid oxidase: The inactive G183R variant. | 2018 Jul |
1 |
| 3 |
29417050 | D-Amino Acid Oxidase-pLG72 Interaction and D-Serine Modulation. | 2018 |
2 |
| 4 |
29946548 | Biochemical Properties of Human D-amino Acid Oxidase Variants and Their Potential Significance in Pathologies. | 2018 |
3 |
| 5 |
30206963 | Insights into the role of d-amino acid oxidase mutations in amyotrophic lateral sclerosis. | 2018 Sep 11 |
1 |
| 6 |
30220232 | Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies. | 2018 Oct |
4 |
| 7 |
30547037 | Human D-Amino Acid Oxidase: Structure, Function, and Regulation. | 2018 |
2 |
| 8 |
28166363 | Elucidating the role of the pLG72 R30K substitution in schizophrenia susceptibility. | 2017 Feb |
1 |
| 9 |
28428746 | Expression of D-Amino Acid Oxidase (DAO/DAAO) and D-Amino Acid Oxidase Activator (DAOA/G72) during Development and Aging in the Human Post-mortem Brain. | 2017 |
4 |
| 10 |
28477547 | Plasma and cerebrospinal fluid G72 protein levels in schizophrenia and major depressive disorder. | 2017 Aug |
1 |
| 11 |
28509930 | Elucidation of inhibitor-binding pockets of d-amino acid oxidase using docking simulation and N-sulfanylethylanilide-based labeling technology. | 2017 Jun 27 |
7 |
| 12 |
28836020 | Change of the N-terminal codon bias combined with tRNA supplementation outperforms the selected fusion tags for production of human D-amino acid oxidase as active inclusion bodies. | 2017 Nov |
1 |
| 13 |
29114206 | Controversial Effects of D-Amino Acid Oxidase Activator (DAOA)/G72 on D-Amino Acid Oxidase (DAO) Activity in Human Neuronal, Astrocyte and Kidney Cell Lines: The N-methyl D-aspartate (NMDA) Receptor Hypofunction Point of View. | 2017 |
1 |
| 14 |
29250527 | Competitive Inhibitors Unveil Structure/Function Relationships in Human D-Amino Acid Oxidase. | 2017 |
5 |
| 15 |
29404340 | Assays of D-Amino Acid Oxidase Activity. | 2017 |
2 |
| 16 |
27400736 | Regulating levels of the neuromodulator d-serine in human brain: structural insight into pLG72 and d-amino acid oxidase interaction. | 2016 Sep |
4 |
| 17 |
25666758 | Genome-wide association study of NMDA receptor coagonists in human cerebrospinal fluid and plasma. | 2015 Dec |
3 |
| 18 |
25701391 | Structure-function relationships in human d-amino acid oxidase variants corresponding to known SNPs. | 2015 Sep |
6 |
| 19 |
24237903 | The degradation (by distinct pathways) of human D-amino acid oxidase and its interacting partner pLG72--two key proteins in D-serine catabolism in the brain. | 2014 Feb |
6 |
| 20 |
24529545 | Immunohistochemical localization of D-serine dehydratase in chicken tissues. | 2014 Jun |
1 |
| 21 |
24795623 | The role of D-serine and glycine as co-agonists of NMDA receptors in motor neuron degeneration and amyotrophic lateral sclerosis (ALS). | 2014 |
1 |
| 22 |
24821597 | Selective oxidation of D-amino acids catalyzed by oligolamellar liposomes intercalated with D-amino acid oxidase. | 2014 Jun 3 |
1 |
| 23 |
24959138 | Activity of D-amino acid oxidase is widespread in the human central nervous system. | 2014 |
3 |
| 24 |
25001371 | Novel human D-amino acid oxidase inhibitors stabilize an active-site lid-open conformation. | 2014 Aug 11 |
2 |
| 25 |
25083578 | The postnatal development of D-serine in the retinas of two mouse strains, including a mutant mouse with a deficiency in D-amino acid oxidase and a serine racemase knockout mouse. | 2014 Sep 17 |
4 |
| 26 |
23116391 | D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy. | 2013 |
6 |
| 27 |
23219954 | Characterization of human DAAO variants potentially related to an increased risk of schizophrenia. | 2013 Mar |
2 |
| 28 |
23391306 | Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro. | 2013 Mar 14 |
3 |
| 29 |
23566269 | 4-Hydroxypyridazin-3(2H)-one derivatives as novel D-amino acid oxidase inhibitors. | 2013 May 9 |
2 |
| 30 |
23631755 | Structural, kinetic, and pharmacodynamic mechanisms of D-amino acid oxidase inhibition by small molecules. | 2013 May 9 |
2 |
| 31 |
24256253 | D-Serine metabolism: new insights into the modulation of D-amino acid oxidase activity. | 2013 Dec |
5 |
| 32 |
21391259 | Effect of D-amino acid oxidase activator (DAOA; G72) on brain function during verbal fluency. | 2012 Jan |
2 |
| 33 |
21950354 | D-Amino acid oxidase-mediated increase in spinal hydrogen peroxide is mainly responsible for formalin-induced tonic pain. | 2012 Mar |
2 |
| 34 |
22454242 | D-amino acid oxidase activator gene (DAOA) variation affects cerebrospinal fluid homovanillic acid concentrations in healthy Caucasians. | 2012 Oct |
2 |
| 35 |
21361869 | Recent advances in the discovery of D-amino acid oxidase inhibitors and their therapeutic utility in schizophrenia. | 2011 |
4 |
| 36 |
21458638 | Determination of sodium benzoate by chiral ligand exchange CE based on its inhibitory activity in D-amino acid oxidase mediated oxidation of D-serine. | 2011 Apr 8 |
2 |
| 37 |
21679769 | Evidence for the interaction of D-amino acid oxidase with pLG72 in a glial cell line. | 2011 Sep |
4 |
| 38 |
21763704 | Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain. | 2011 Oct-Nov |
4 |
| 39 |
21889486 | Development of a high-throughput method for the determination of pharmacological levels of plasma D-serine. | 2011 Dec 15 |
4 |
| 40 |
21981077 | Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase. | 2011 Nov |
2 |
| 41 |
19329549 | The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia. | 2010 Jul |
2 |
| 42 |
19786963 | The neurobiology of D-amino acid oxidase and its involvement in schizophrenia. | 2010 Feb |
2 |
| 43 |
19945264 | Development of an implantable D-serine biosensor for in vivo monitoring using mammalian D-amino acid oxidase on a poly (o-phenylenediamine) and Nafion-modified platinum-iridium disk electrode. | 2010 Feb 15 |
3 |
| 44 |
20091774 | D-Serine metabolism in C6 glioma cells: Involvement of alanine-serine-cysteine transporter (ASCT2) and serine racemase (SRR) but not D-amino acid oxidase (DAO). | 2010 Jun |
3 |
| 45 |
20417696 | N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? | 2010 Sep 30 |
1 |
| 46 |
20521334 | Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment. | 2010 Aug |
5 |
| 47 |
20648222 | The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors. | 2010 May 27 |
1 |
| 48 |
20876609 | Potential cytotoxic effect of hydroxypyruvate produced from D-serine by astroglial D-amino acid oxidase. | 2010 Dec |
5 |
| 49 |
19309736 | Relevance of weak flavin binding in human D-amino acid oxidase. | 2009 Apr |
6 |
| 50 |
19586804 | Determination of D-serine and D-alanine in the tissues and physiological fluids of mice with various D-amino-acid oxidase activities using two-dimensional high-performance liquid chromatography with fluorescence detection. | 2009 Aug 15 |
1 |